BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1528344)

  • 1. Antimicrobial gentamicin activity in the presence of exogenous protease inhibitor (Bowman-Birk inhibitor) in gentamicin-induced nephrotoxicity in rats.
    Smetana S; Khalef S; Bar-Khayim Y; Birk Y
    Nephron; 1992; 61(1):68-72. PubMed ID: 1528344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of exogenous protease inhibitor (Bowmann-Birk inhibitor) in gentamicin-induced nephrotoxicity in rats.
    Smetana S; Khalef S; Hurwitz N; Bar-Khayim Y; Birk Y
    Contrib Nephrol; 1990; 83():183-90. PubMed ID: 2100710
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced urinary trypsin inhibitory activity in gentamicin-induced nephrotoxicity in rats.
    Smetana S; Khalef S; Nitsan Z; Hurwitz N; Miskin A; Bar-Khayim Y; Birk Y
    Clin Chim Acta; 1988 Sep; 176(3):333-42. PubMed ID: 3180482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of 3-methylcholanthrene-induced cellular transformation by timed administration of the Bowman-Birk protease inhibitor.
    St Clair WH
    Carcinogenesis; 1991 May; 12(5):935-7. PubMed ID: 2029760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interaction between gentamicin and pyridoxal-5-phosphate on functional and metabolic parameters in kidneys of female Sprague-Dawley rats.
    Smetana S; Khalef S; Kopolovic G; Bar-Khayim Y; Birk Y; Kacew S
    Ren Fail; 1992; 14(2):147-53. PubMed ID: 1636020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies against soybean Bowman-Birk inhibitor recognize the protease-reactive loops.
    Mao Y; Lai C; Vogtentanz G; Schmidt B; Day T; Miller J; Brandon DL; Chen D
    Protein J; 2005 Jul; 24(5):275-82. PubMed ID: 16284725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.
    Chen YW; Huang SC; Lin-Shiau SY; Lin JK
    Carcinogenesis; 2005 Jul; 26(7):1296-306. PubMed ID: 15746161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
    Wan XS; Serota DG; Ware JH; Crowell JA; Kennedy AR
    Nutr Cancer; 2002; 43(2):167-73. PubMed ID: 12588697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyaspartic acid protects against gentamicin nephrotoxicity in the rat.
    Ramsammy LS; Josepovitz C; Lane BP; Kaloyanides GJ
    J Pharmacol Exp Ther; 1989 Jul; 250(1):149-53. PubMed ID: 2746494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin, a pineal hormone with antioxidant property, protects against gentamicin-induced nephrotoxicity in rats.
    Shifow AA; Kumar KV; Naidu MU; Ratnakar KS
    Nephron; 2000 Jun; 85(2):167-74. PubMed ID: 10867523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Bowman-Birk inhibitor on rat colon carcinogenesis.
    Kennedy AR; Billings PC; Wan XS; Newberne PM
    Nutr Cancer; 2002; 43(2):174-86. PubMed ID: 12588698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate.
    Kennedy AR; Szuhaj BF; Newberne PM; Billings PC
    Nutr Cancer; 1993; 19(3):281-302. PubMed ID: 8346077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity.
    Malkowicz SB; Liu SP; Broderick GA; Wein AJ; Kennedy AR; Levin RM
    Neurourol Urodyn; 2003; 22(1):54-7. PubMed ID: 12478602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Disulfide Bond Reduction on the Conformation and Trypsin/Chymotrypsin Inhibitor Activity of Soybean Bowman-Birk Inhibitor.
    He H; Li X; Kong X; Zhang C; Hua Y; Chen Y
    J Agric Food Chem; 2017 Mar; 65(11):2461-2467. PubMed ID: 28249116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR
    Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of a Bowman-Birk inhibitor active towards trypsin but not chymotrypsin in Lupinus albus seeds.
    Scarafoni A; Consonni A; Galbusera V; Negri A; Tedeschi G; Rasmussen P; Magni C; Duranti M
    Phytochemistry; 2008 Jun; 69(9):1820-5. PubMed ID: 18474386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bowman-Birk inhibitor suppresses production of superoxide anion radicals in differentiated HL-60 cells.
    Ware JH; Wan XS; Kennedy AR
    Nutr Cancer; 1999; 33(2):174-7. PubMed ID: 10368813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteases occurring in the cell membrane: a possible cell receptor for the Bowman-Birk type of protease inhibitors.
    Yavelow J; Caggana M; Beck KA
    Cancer Res; 1987 Mar; 47(6):1598-601. PubMed ID: 3545448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43.
    Saito T; Sato H; Virgona N; Hagiwara H; Kashiwagi K; Suzuki K; Asano R; Yano T
    Cancer Lett; 2007 Aug; 253(2):249-57. PubMed ID: 17343982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of allicin against gentamicin-induced nephrotoxicity in rats.
    El-Kashef DH; El-Kenawi AE; Suddek GM; Salem HA
    Int Immunopharmacol; 2015 Dec; 29(2):679-686. PubMed ID: 26391062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.